Characterizing oseltamivir use among community-dwelling patients diagnosed with influenza virus infection, 2023-2025

Authors

• Emily A McNair, Centers for Disease Control and Prevention
• Stephanie A Fritz, Washington University School of Medicine in St. Louis
• Rachel M Presti, Washington University School of Medicine in St. Louis
• Stacey House, Washington University School of Medicine in St. Louis
• et al.

Journal

Open Forum Infectious Diseases

Publication Date

10-1-2026

Volume

13

Issue

10

First Page

ofag587

Document Type

Open Access Publication

DOI

10.1093/ofid/ofag587

Rights and Permissions

Emily A McNair, Jennie H Kwon, Carlos G Grijalva, Son H McLaren, Jessica E Biddle, Samantha Dean, Lydia Bristol, Elizabeth B White, Stephanie A Fritz, Rachel M Presti, Caroline A O’Neil, Ellen Sano, Celibell Vargas, Jonathan Schmitz, Yuwei Zhu, Theresa A Scott, Stacey House, H Keipp Talbot, Melissa S Stockwell, Alexandra M Mellis, on behalf of the RVTN Flu study group, Characterizing Oseltamivir Use Among Community-Dwelling Patients Diagnosed With Influenza Virus Infection, 2023–2025, Open Forum Infectious Diseases, Volume 13, Issue 10, October 2026, ofag587, https://doi.org/10.1093/ofid/ofag587. https://academic.oup.com/ofid/article/13/10/ofag587/8824047?login=true. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2026. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Recommended Citation

McNair, Emily A; Fritz, Stephanie A; Presti, Rachel M; House, Stacey; and et al., "Characterizing oseltamivir use among community-dwelling patients diagnosed with influenza virus infection, 2023-2025." Open Forum Infectious Diseases. 13, 10. ofag587 (2026).
https://digitalcommons.wustl.edu/oa_4/7727

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.